<DOC>
	<DOC>NCT02286934</DOC>
	<brief_summary>A Clinical Study to Evaluate the Effect of Cytochrome P450 2D6 polymorphism on Pharmacokinetics/Pharmacodynamics After Multiple Administration of Carvedilol</brief_summary>
	<brief_title>Cytochrome P450 2D6 Genotype on the Clinical Effect of Carvedilol</brief_title>
	<detailed_description>This study has an open-label, one-sequence, multiple drug administration design. The purpose of this study is as follows; To evaluate the change of the result of Isoproterenol Sensitivity Test according to Cytochrome P450 2D6 genotype after the multiple administration of carvedilol</detailed_description>
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Isoproterenol</mesh_term>
	<criteria>Healthy Subjects aged 20 45 years A body mass index (BMI) in the range 18.0 kg/m2 (inclusive) 27.0 kg/m2 (inclusive). Sufficient ability to understand the nature of the study and any hazards of participating in it. Provide written informed consent after being fully. informed about the study procedures. Presence or history of hypersensitivity or allergic reactions to drugs including investigational product (Carvedilol, Isoproterenol). Subject judged not eligible for study participation by investigator.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Carvedilol</keyword>
	<keyword>CYP2D6</keyword>
	<keyword>Isoproterenol Sensitivity Test</keyword>
</DOC>